IP Library Assignment 072955/0496
Patent Assignment
Reel/Frame 072955/0496

Release of Security Interest

Recorded: 2025-11-19 Pages: 8
Assignor
BANK OF MONTREAL
Executed: 2025-11-17
Assignees
APTEVO BIOTHERAPEUTICS LLC
29 N WACKER DR, SUITE 704, CHICAGO, ILLINOIS, 60606
MEDEXUS PHARMACEUTICALS, INC.
35 NIXON ROAD, SUITE 1, BOLTON, L7E 1K1, CANADA
MEDEXUS PHARMA, INC.
29 N WACKER DR, SUITE 1, BOLTON, L7E 1K1, CANADA
Covered Properties (4)
Method of Producing Recombinant Vitamin K Dependent Proteins
Patent: 9,587,008 →
Application: 14/475,881 →
Publication: US 2014/0369994
Stabilized Factor Ix Formulations Containing Trehalose
Application: 16/940,885 →
Publication: US 2021/0177976
Recombinant Vitamin K Dependent Proteins with High Sialic Acid Content and Methods of Preparing Same
Application: 17/548,124 →
Publication: US 2023/0272360
Method of Producing Biologically Active Vitamin K Dependent Proteins by Recombinant Methods
Application: 17/970,051 →
Publication: US 2023/0287471
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 26, 2015
From: GRIFFITH, MICHAEL J.
To: INSPIRATION BIOPHARMACEUTICALS, INC.
Reel/Frame 035263/0414 →
Assignment of Assignor's Interest Mar 26, 2015
From: CANGENE CORPORATION
To: CNJ HOLDINGS, INC.
Reel/Frame 035263/0679 →
Assignment of Assignor's Interest Mar 26, 2015
From: INSPIRATION BIOPHARMACEUTICALS, INC.
To: CANGENE CORPORATION
Reel/Frame 035263/0590 →
Assignment of Assignor's Interest Mar 26, 2015
From: DROHAN, WILLIAM N.
To: INSPIRATION BIOPHARMACEUTICALS, INC.
Reel/Frame 035263/0487 →
Merger Dec 14, 2016
From: CNJ HOLDINGS INC.
To: CANGENE CORPORATION
Reel/Frame 040735/0788 →
Assignment of Assignor's Interest Dec 14, 2016
From: CANGENE CORPORATION
To: 407850 MANITOBA PARTNERSHIP
Reel/Frame 040735/0805 →
Assignment of Assignor's Interest Dec 14, 2016
From: CANGENE CORPORATION; 407850 MANITOBA PARTNERSHIP; EMERGENT PROTECTIVE PRODUCTS CANADA ULC
To: APTEVO BIOTHERAPEUTICS LLC
Reel/Frame 040735/0833 →
Security Interest Feb 7, 2019
From: APTEVO THERAPEUTICS INC.; APTEVO BIOTHERAPEUTICS INC.; APTEVO RESEARCH AND DEVELOPMENT LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 048270/0813 →
Security Interest Mar 6, 2020
From: MEDEXUS PHARMACEUTICALS INC.; MEDEXUS INC.; MEDEXUS PHARMA, INC.; MI ACQUISITIONS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 052039/0633 →
Release of Security Interest Mar 6, 2020
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: APTEVO THEAPEUTICS INC.; APTEVO BIOTHERAPEUTICS LLC; APTEVO RESEARCH AND DEVELOPMENT LLC
Reel/Frame 052039/0258 →
Security Interest (Revolving) May 8, 2020
From: MEDEXUS PHARMACEUTICALS INC.; MEDEXUS INC.; MEDEXUS PHARMA, INC.; MI ACQUISITIONS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 052617/0579 →
Security Agreement Mar 8, 2023
From: APTEVO BIOTHERAPEUTICS LLC
To: BANK OF MONTREAL, AS ADMINISTRATIVE AGENT
Reel/Frame 062992/0829 →
Release of Security Interest Mar 21, 2023
From: MIDCAP FINANCIAL TRUST
To: MEDEXUS PHARMA INC.; MEDEXUS PHARMACEUTICALS INC.; MI ACQUISITIONS, INC.,; APTEVO BIOTHERAPEUTICS LLC,
Reel/Frame 063049/0761 →